Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Groundwork BioAg is a leading agricultural biotechnology company that specializes in the production of highly concentrated mycorrhizal inoculants. The company's flagship technology leverages symbiotic fungi to enhance plant nutrient uptake, improve crop yields, and increase resilience against environmental stressors such as drought and soil salinity. By focusing on mass-production techniques for mycorrhiza, Groundwork BioAg has made these biological solutions accessible for broad-acre agriculture globally. Their products, marketed under the Rootella brand, also play a significant role in regenerative agriculture by facilitating carbon sequestration in the soil. The company is headquartered in Israel and serves major agricultural markets across the Americas, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GroundWork.